Rockville, March 27, 2023 (GLOBE NEWSWIRE) -- The market for MRI-guided radiation therapy systems is currently valued at US$ 545.1 million and is anticipated to generate US$ 2.89 billion in sales by the end of 2033. According to Fact.MR study, sales of MRI-guided radiation therapy systems will significantly increase at a 18.1% CAGR over the next 10 years.
Since MRI-guided radiation therapy systems are widely used in the treatment of cancer, the rising incidence of various malignancies is anticipated to significantly boost market growth over the course of the forecast period. It is also projected that rising capital spending on establishing healthcare infrastructure in developing economies would increase shipments of MRI-guided radiation therapy equipment in the future.
Download Free Sample Copy of This Report https://www.factmr.com/connectus/sample?flag=S&rep_id=2572
Drivers
Restraints
Trends
Get Customization on this Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=2572
Regional Landscape:United States is expected to account for a substantial share in the market. Various factors such as developed healthcare infrastructure and the significant presence of reimbursement policies in the United States are expected to boost the adoption of MRI-guided radiation therapy systems.
Competitive LandscapeMRI-guided Radiation therapy systems market is highly consolidated. Companies such as Elekta AB and ViewRay are dominating the global market and currently, account for around 80% of the global market share.
In addition to this, companies are receiving FDA approvals to expand their sales potential across various countries.
Key Companies Profiled
Quick Buy & Expand Your Horizons: MRI-guided Radiation Therapy Systems Market Report https://www.factmr.com/checkout/2572
Key Questions Covered in the MRI-guided Radiation Therapy Systems Market Report
Check out more related studies published by Fact.MR Research:Hormone Replacement Therapy Market Size: The global hormone replacement therapy market size is estimated at USD 18.4 Billion in 2022 and is forecast to surpass USD 32.8 Billion by 2032, growing at a CAGR of 5.9% from 2022 to 2032.
Dual Therapy Stent Market Sales: The global duel therapy stent market sales valued at USD 11.09 Billion in 2022. The market is estimated to surpass a valuation of USD 23.07 Billion by 2032. The forecast duration of this report is 2022- 2032.
Rheumatoid Arthritis Stem Cell Therapy Market Share: The global rheumatoid arthritis stem cell therapy market share account for a share of USD 23.42 Billion in 2022. The market is anticipated to surpass the valuation of USD 33.30 Billion by end of the forecast period i.e. 2032. The rheumatoid arthritis stem cell market is expected to grow with a CAGR of 4.5 %.
Dual Antiplatelet Therapy Market Growth: Emergence of more effective oral and other anticoagulants may also hamper the market growth. In addition, high cost associated with the therapy and lack of its awareness in various regions across the globe will possibly confine the dual antiplatelet therapy market growth.
About Fact.MRWe are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our clients satisfaction.
Contact: US Sales Office11140Rockville PikeSuite 400Rockville, MD20852United StatesTel: +1 (628) 251-1583, +353-1-4434-232 (D) Connect to Author: Mr. Shambhu Nath JhaEmail : shambhu@factmr.com Sales Team :sales@factmr.com Follow Us:LinkedIn | Twitter | YouTube
See the article here:
MRI-guided Radiation Therapy Systems Revenue to Top US$2.89 ... - GlobeNewswire